Related Experiment Video
Updated: Feb 6, 2026

Differentiating Functional Roles of Gene Expression from Immune and Non-immune Cells in Mouse Colitis by Bone Marrow Transplantation
Published on: October 1, 2012
Improved Bowel Function in Patients with Spina Bifida After Bone Marrow-Derived Mononuclear Cell Transplantation: A
Nguyen Thanh Liem1, Vu Duy Chinh2, Nguyen Thi Thinh3
1Stem Cell and Immune Cell Department, Vinmec Research Institute of Stem Cell and Gene Technology, Times City, Ha Noi, Vietnam.
Insights
Bone marrow-derived mononuclear cells transplantation improved bowel function in two children with spina bifida. This novel treatment offers hope for managing bowel dysfunction in spina bifida patients.
Area of Science:
- Regenerative Medicine
- Pediatric Gastroenterology
- Spinal Cord Injury Research
Background:
- Spina bifida frequently causes bowel dysfunction, affecting over 70% of patients.
- Conventional treatments for neurogenic bowel dysfunction in spina bifida often provide limited efficacy.
- Myelomeningocele repair is a common intervention, but bowel dysfunction persists post-surgery.
Observation:
- Two pediatric patients with spina bifida and severe bowel dysfunction post-myelomeningocele repair were treated.
- Bone marrow-derived mononuclear cells (BMMNC) transplantation was administered to both patients without complications.
- Follow-up periods extended to 21 months for one patient and 16 months for the other.
Findings:
- Both patients demonstrated significant improvement in bowel function post-BMMNC transplantation.
- Normal defecation was achieved and sustained in the treated pediatric patients.
- The study highlights a potential therapeutic benefit of BMMNC transplantation for bowel dysfunction.
Implications:
- BMMNC transplantation presents a promising therapeutic avenue for improving bowel function in spina bifida.
- This approach may offer a novel solution for refractory neurogenic bowel dysfunction.
- Further research into BMMNC transplantation could advance treatment strategies for pediatric patients with spina bifida.
Abstract:
BACKGROUND Bowel dysfunction is observed in 42.2-71.2% of patients with spina bifida. Traditional treatments yield limited results. The objective of this paper is to report on improvement in bowel function in 2 children with spina bifida following bone marrow-derived mononuclear cells transplantation. CASE REPORT Two patients - 14 years old and 11 years old - with bowel dysfunction after myelomeningocele repair underwent 2 BMMNC transplantations without complications. Those patients had normal defecation, assessed through follow-ups of 21 months and 16 months, respectively. CONCLUSIONS BMMNC transplantation can improve bowel function, as demonstrated in 2 patients with spina bifida.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The Derivative as a Function
Derivatives of the Trigonometric Functions
Derivatives of Logarithmic Functions
Second Derivatives of Implicit Functions
Data Reporting and Recording

